NDA holder for Lidoderm. R&D base in the U.S. Responsible for clinical trials.
Teikoku Pharma USA,Inc.
Teikoku Pharma USA, Inc. (TPUSA) was established on April 1, 1997, in Silicon Valley, as Teikoku Seiyaku’s first overseas base.
As well as undertaking the importation of Lidoderm, the first prescription medicated plaster to have obtained FDA approval, we also act as an intermediary for other overseas activities including surveying development of new products in the U.S. and licensing into Japan.
Headquarters
- 1718 Ringwood Avenue, San Jose CA95131 USA
- TEL +1-408-501-1800
- FAX +1-408-501-1900
Production and sales base in China, combining the business know-how of Fuso Chemical in China and the technology by Teikoku Seiyaku.
Fuso Teiyaku Qingdao Co.,Ltd.
On June 18, 2003, three companies, Teikoku Seiyaku, Fuso Chemical Co,. Ltd. and Qingdao Fuso Refining & Processing Co., Ltd. combined to form the new Fuso Teiyaku Qingdao Co., Ltd., based in Shandong in China.
At Fuso Teiyaku Qingdao Co., Ltd., we have incorporated Teikoku Seiyaku’s half-century of research into transdermal preparations, and its manufacturing technology, to become Teikoku Seiyaku’s first Chinese poultice plant. Here we produce medical adhesive products and external aqueous gel preparations. Our products are sold not only within China, but also to the Japanese and other international markets.
Headquarters
- No.200 Zhuzhou Road, Laoshan District,Qingdao, Shandong 266101, China
- TEL +86-532-8870-5600
- FAX +86-532-8870-3599
